|
URB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.359400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593230E-04 |
| Normal-vs-Stage2 |
2.135400E-01 |
| Normal-vs-Stage3 |
7.407200E-04 |
| Normal-vs-Stage4 |
3.656300E-03 |
| Stage1-vs-Stage2 |
5.275800E-02 |
| Stage1-vs-Stage3 |
8.473400E-01 |
| Stage1-vs-Stage4 |
7.887000E-01 |
| Stage2-vs-Stage3 |
7.398300E-02 |
| Stage2-vs-Stage4 |
1.156420E-01 |
| Stage3-vs-Stage4 |
9.158400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.355150E-03 |
| Normal-vs-AfricanAmerican |
3.641200E-03 |
| Normal-vs-Asian |
5.222100E-04 |
| Caucasian-vs-AfricanAmerican |
5.902600E-01 |
| Caucasian-vs-Asian |
2.840800E-01 |
| AfricanAmerican-vs-Asian |
6.512800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.036100E-04 |
| Normal-vs-Female |
6.417600E-04 |
| Male-vs-Female |
1.642960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.761100E-04 |
| Normal-vs-Age(41-60Yrs) |
9.88170000000288E-05 |
| Normal-vs-Age(61-80Yrs) |
1.858450E-02 |
| Normal-vs-Age(81-100Yrs) |
5.522200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.281800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.154800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.247200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.252550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.461400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.858600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.269640E-01 |
| Classical-VS-Follicular |
6.092400E-02 |
| Classical-VS-Other |
7.146500E-02 |
| Classical-VS-Normal |
5.095100E-03 |
| Tall-VS-Follicular |
7.386400E-01 |
| Tall-VS-Other |
3.079400E-01 |
| Tall-VS-Normal |
1.739160E-03 |
| Follicular-VS-Other |
2.006600E-01 |
| Follicular-VS-Normal |
1.370310E-04 |
| Other-VS-Normal |
5.279900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.011400E-04 |
| Normal-vs-N1 |
9.178700E-04 |
| N0-vs-N1 |
3.675000E-01 |
|
|
